Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Competitive Landscape: Some of the major market players in the GLP-1 receptor agonist industry include Amgen Inc., Eli Lilly and Company, Hanmi Pharm Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Novo Nordisk A/S, Paige Biomedicine (Suzhou) Co., Ltd., Sanofi S.A., among many others
Salt form not disclosed publicly
GHK-Cu's ability to suppress TGF-1 secretion suggests a mechanism distinct from but complementary to finasteride (which blocks androgen conversion) and minoxidil (which stimulates growth directly)
PDRN (Polydeoxyribonucleotide): the adenosine A2A receptor agonist PDRN is a mixture of short and long DNA polymers extracted, in commercial preparations, from the gametes of salmon trout
US$ 21.54
US$ 29.38
US$ 29.45
US$ 27.69
US$ 26.38
